134 related articles for article (PubMed ID: 26558328)
21. T-category remains an important prognostic factor for oropharyngeal carcinoma in the era of human papillomavirus.
Mackenzie P; Pryor D; Burmeister E; Foote M; Panizza B; Burmeister B; Porceddu S
Clin Oncol (R Coll Radiol); 2014 Oct; 26(10):643-7. PubMed ID: 25001635
[TBL] [Abstract][Full Text] [Related]
22. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma.
Ang KK; Sturgis EM
Semin Radiat Oncol; 2012 Apr; 22(2):128-42. PubMed ID: 22385920
[TBL] [Abstract][Full Text] [Related]
23. Salvage surgery for recurrent cancers of the oropharynx: comparing TORS with standard open surgical approaches.
White H; Ford S; Bush B; Holsinger FC; Moore E; Ghanem T; Carroll W; Rosenthal E; Sweeny L; Magnuson JS
JAMA Otolaryngol Head Neck Surg; 2013 Aug; 139(8):773-8. PubMed ID: 23949352
[TBL] [Abstract][Full Text] [Related]
24. The relevance of the lymph node ratio as predictor of prognosis is higher in HPV-negative than in HPV-positive oropharyngeal squamous cell carcinoma.
Meyer MF; Meinrath J; Seehawer J; Lechner A; Odenthal M; Quaas A; Semrau R; Huebbers CU; Marnitz S; Büttner R; Beutner D
Clin Otolaryngol; 2018 Feb; 43(1):192-198. PubMed ID: 28714274
[TBL] [Abstract][Full Text] [Related]
25. Association of HPV status with survival after surgical salvage of oropharyngeal cancers.
Patel TR; Lee S; Tajudeen BA; Stenson K; Bhayani M; Al-Khudari S
Am J Otolaryngol; 2022; 43(4):103491. PubMed ID: 35567838
[TBL] [Abstract][Full Text] [Related]
26. Oligometastatic status as predictor of survival in metastatic human papillomavirus-positive oropharyngeal carcinoma.
Albergotti WG; Abberbock S; Mathews F; Ferris RL; Johnson JT; Duvvuri U; Kim S
Head Neck; 2018 Aug; 40(8):1685-1690. PubMed ID: 29756301
[TBL] [Abstract][Full Text] [Related]
27. Impact of comorbidity and anemia in patients with oropharyngeal cancer primarily treated with surgery in the human papillomavirus era.
Baumeister P; Rauch J; Jacobi C; Kisser U; Betz C; Becker S; Reiter M
Head Neck; 2017 Jan; 39(1):7-16. PubMed ID: 27385398
[TBL] [Abstract][Full Text] [Related]
28. Management of the "violated neck" in the era of chemoradiation.
Loyo M; Johnson JT; Westra WH; Chiosea SI; Gourin CG
Laryngoscope; 2011 Nov; 121(11):2349-58. PubMed ID: 21993776
[TBL] [Abstract][Full Text] [Related]
29. Weekly cisplatin and radiotherapy for low risk, locoregionally advanced human papillomavirus-positive oropharyngeal squamous cell carcinoma.
Urban D; Corry J; Solomon B; Lim AM; Fua T; Coleman A; D'Costa I; Tiong A; Liu C; Peters LJ; Rischin D
Head Neck; 2016 Apr; 38 Suppl 1():E1117-21. PubMed ID: 26461454
[TBL] [Abstract][Full Text] [Related]
30. Outcomes of surgically treated human papillomavirus-related oropharyngeal squamous cell carcinoma with N3 disease.
Zenga J; Haughey BH; Jackson RS; Adkins DR; Aranake-Chrisinger J; Bhatt N; Gay HA; Kallogjeri D; Martin EJ; Moore EJ; Paniello RC; Rich JT; Thorstad WL; Nussenbaum B
Laryngoscope; 2017 Sep; 127(9):2033-2037. PubMed ID: 28008626
[TBL] [Abstract][Full Text] [Related]
31. Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocols.
Haring CT; Kana LA; Dermody SM; Brummel C; McHugh JB; Casper KA; Chinn SB; Malloy KM; Mierzwa M; Prince MEP; Rosko AJ; Shah J; Stucken CL; Shuman AG; Brenner JC; Spector ME; Worden FP; Swiecicki PL
Cancer; 2023 Sep; 129(18):2817-2827. PubMed ID: 37162461
[TBL] [Abstract][Full Text] [Related]
32. Management of Recurrent and Metastatic HPV-Positive Oropharyngeal Squamous Cell Carcinoma after Transoral Robotic Surgery.
Sims JR; Van Abel K; Martin EJ; Lohse CM; Price DL; Olsen KD; Moore EJ
Otolaryngol Head Neck Surg; 2017 Jul; 157(1):69-76. PubMed ID: 28374634
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of Human Papillomavirus-Associated Head and Neck Cancers in a Veteran Population.
Shay SG; Chang E; Lewis MS; Wang MB
JAMA Otolaryngol Head Neck Surg; 2015 Sep; 141(9):790-6. PubMed ID: 26270931
[TBL] [Abstract][Full Text] [Related]
34. Treatment results and prognostic factors for advanced squamous cell carcinoma of the head and neck treated with salvage surgery after concurrent chemoradiotherapy.
Taguchi T; Nishimura G; Takahashi M; Shiono O; Komatsu M; Sano D; Yabuki KI; Arai Y; Yamashita Y; Yamamoto K; Sakuma Y; Oridate N
Int J Clin Oncol; 2016 Oct; 21(5):869-874. PubMed ID: 26908193
[TBL] [Abstract][Full Text] [Related]
35. Epithelial to mesenchymal transition and HPV infection in squamous cell oropharyngeal carcinomas: the papillophar study.
Lefevre M; Rousseau A; Rayon T; Dalstein V; Clavel C; Beby-Defaux A; Pretet JL; Soussan P; Polette M; Lacau Saint Guily J; Birembaut P;
Br J Cancer; 2017 Jan; 116(3):362-369. PubMed ID: 28072763
[TBL] [Abstract][Full Text] [Related]
36. Oncologic outcomes of surgically treated early-stage oropharyngeal squamous cell carcinoma.
Kass JI; Giraldez L; Gooding W; Choby G; Kim S; Miles B; Teng M; Sikora AG; Johnson JT; Myers EN; Duvvuri U; Genden EM; Ferris RL
Head Neck; 2016 Oct; 38(10):1467-71. PubMed ID: 27080244
[TBL] [Abstract][Full Text] [Related]
37. The impact of HPV infection, smoking history, age and operability of the patient on disease-specific survival in a geographically defined cohort of patients with oropharyngeal squamous cell carcinoma.
Ljøkjel B; Haave H; Lybak S; Aarstad HH; Karlsdottir A; Vintermyr OK; Aarstad HJ
Acta Otolaryngol; 2014 Sep; 134(9):964-73. PubMed ID: 24963968
[TBL] [Abstract][Full Text] [Related]
38. Association of Extracapsular Spread With Survival According to Human Papillomavirus Status in Oropharynx Squamous Cell Carcinoma and Carcinoma of Unknown Primary Site.
Kharytaniuk N; Molony P; Boyle S; O'Leary G; Werner R; Heffron C; Feeley L; Sheahan P
JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):683-690. PubMed ID: 27196434
[TBL] [Abstract][Full Text] [Related]
39. Salvage surgery in recurrent head and neck squamous cell carcinoma: Oncologic outcome and predictors of disease free survival.
Hamoir M; Holvoet E; Ambroise J; Lengelé B; Schmitz S
Oral Oncol; 2017 Apr; 67():1-9. PubMed ID: 28351561
[TBL] [Abstract][Full Text] [Related]
40. What is the best treatment for patients with human papillomavirus-positive and -negative oropharyngeal cancer?
Urban D; Corry J; Rischin D
Cancer; 2014 May; 120(10):1462-70. PubMed ID: 24578320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
